EXPE up +1.16% percent right now. $EXPE High is at 86.17

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
EXPE up +1.16% percent right now. $EXPE High is at 86.17 and the Low 84.79 with current volume of 371,146.

Recent News posted below.

EXPE Expedia Inc Recent Headline News

Expedia Earnings Hindsight: Up 5.4% in Last 11 Days (EXPE)
Comtex SmarTrend(R) - 1 hr 52 mins ago
When Expedia (NASDAQ:EXPE) reported earnings 11 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $1.74 on sales of $1.7 billion. Expedia actually reported earnings of $1.93 per share on sales of $1.7 billion, beating EPS estimates by $0.19 and beating revenue estimates by $34.3 million. Shares of Expedia have climbed from $80.73 to $85.11, representing a gain of 5.4% since the company reported earnings 11 days ago.
EXPE: 86.25 (+1.14)

Expedia, Inc. Licenses Routehappy Scores & Happiness Factors API For Integration Into Search Results, Helping Flyers Find Happiness
PR Newswire - Mon Nov 10, 9:30AM CST
Routehappy, the product differentiation platform for air travel, today announced it entered a partnership with Expedia, Inc. (NASDAQ: EXPE), one of the world's largest travel companies, for full access to its proprietary Scores & Happiness Factors API.
EXPE: 86.25 (+1.14)

HomeAway (AWAY) Beats Q3 Earnings on Higher Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:40AM CST
HomeAway, Inc. (AWAY) reported adjusted third-quarter 2014 earnings of 11 cents per share, exceeding the Zacks Consensus Estimate of 7 cents. The adjusted earnings per share exclude one-time items but include stock-based compensation expense.
AWAY: 29.48 (+0.27), TRIP: 73.17 (-0.48), EXPE: 86.25 (+1.14), PCLN: 1,113.97 (+19.36)

Strong forecast for hotel industry
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:20AM CST

WYN: 77.70 (+0.38), HLT: 25.12 (+0.15), CHH: 53.05 (+0.34), HMIN: 30.55 (+0.11), EXPE: 86.25 (+1.14), MAR: 76.48 (+0.98), H: 57.59 (+0.06), IHG: 39.05 (+0.80), BEL: 11.21 (+0.20), STAY: 18.36 (+0.06), HOT: 76.81 (+0.38)

Online Travel & Advertising Boosted by Stronger Economy - Zacks Analyst Interviews
Sejuti Banerjea - Zacks Investment Research - Mon Nov 10, 12:05AM CST
Online Travel & Advertising Boosted by Stronger Economy - Zacks Analyst Interviews
YHOO: 49.29 (+0.74), QUNR: 25.84 (+0.13), LNKD: 229.76 (+6.72), FB: 75.22 (-0.38), EXPE: 86.25 (+1.14), TRIP: 73.17 (-0.48), MMYT: 29.35 (+0.77), GOOGL: 560.44 (+8.62), CTRP: 56.45 (+2.15), TWTR: 39.81 (-0.50), OWW: 7.56 (-0.12), PCLN: 1,113.97 (+19.36)

Online Travel & Advertising Boosted by Stronger Economy - Industry Outlook
Sejuti Banerjea - Zacks Investment Research - Mon Nov 10, 12:05AM CST
Online Travel & Advertising Boosted by Stronger Economy - Industry Outlook
YHOO: 49.29 (+0.74), QUNR: 25.84 (+0.13), LNKD: 229.76 (+6.72), FB: 75.22 (-0.38), EXPE: 86.25 (+1.14), TRIP: 73.17 (-0.48), MMYT: 29.35 (+0.77), GOOGL: 560.44 (+8.62), CTRP: 56.45 (+2.15), TWTR: 39.80 (-0.51), OWW: 7.56 (-0.12), PCLN: 1,113.97 (+19.36)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.46 (-0.97), LCI: 51.39 (+1.22), AKRX: 35.68 (-0.91), AFSI: 50.48 (+0.59), EXPE: 86.25 (+1.14), FFIV: 126.96 (+0.30), SLXP: 93.11 (+1.64), MPWR: 44.66 (-0.03), TMH: 53.95 (-0.19), ATHM: 44.70 (+1.07)

Financial Results, New Offering, and Comparable Store Sales - Research Reports on Expedia, Royal Caribbean Cruises, L Brands, DISH and Discovery
PR Newswire - Fri Nov 07, 8:05AM CST
Today, Analysts Review released its research reports regarding Expedia Inc. (NASDAQ: EXPE), Royal Caribbean Cruises Ltd. (NYSE: RCL), L Brands Inc. (NYSE: LB), DISH Network Corp. (NASDAQ: DISH) and Discovery Communications Inc. (NASDAQ: DISCK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7778-100free.
DISCK: 32.14 (-0.20), RCL: 67.80 (+0.60), LB: 76.28 (+0.67), EXPE: 86.25 (+1.14), DISH: 63.43 (-0.28)

eLong to Announce Third Quarter 2014 Unaudited Financial Results on November 12, 2014
PR Newswire - Fri Nov 07, 4:00AM CST
eLong, Inc. (Nasdaq: LONG - News ), a leading mobile and online travel service provider in China, today announced that it will report its financial results for the third quarter 2014 on Wednesday November 12, 2014, at 7:30 pm Eastern Time (Thursday, November 13, 2014, 8:30 am Beijing Time).
EXPE: 86.25 (+1.14), LONG: 18.40 (-0.10)

Comparing Priceline To Expedia - Why Priceline Comes Out On Top
Stock Market Sherpa - at Seeking Alpha - Fri Nov 07, 1:10AM CST

EXPE: 86.25 (+1.14), PCLN: 1,113.97 (+19.36)

Marriott, Coke and Others Utilizing Oculus Rift as Virtual Reality Could Transform Industries
ACCESSWIRE - Thu Nov 06, 8:40AM CST
Whitefish, MT / November 6, 2014 / Most people have seen a "virtual tour" of something, such as videos of houses for sale on Zillow (NYSE:Z) or the new virtual tour of the One World Trade Center observatory, but that technology still doesn't really give a person a feeling of being there because it still lacks a full perspective. Imagine when the user is in full control; able to back up, look down and around and the video responds accordingly. What about any audio, which still lacks direction in existing so-called virtual tours? That's what virtual reality (VR) is going to bring to the table and it's going to transform much more than just gaming with its endless possibilities and applications.
KO: 42.38 (+0.06), CCL: 40.26 (-0.14), FB: 75.22 (-0.38), SNE: 20.52 (+0.90), FCAU: 11.06 (+0.12), TM: 118.18 (-0.49), MAR: 76.48 (+0.98), OWW: 7.56 (-0.12), EXPE: 86.25 (+1.14), Z: 106.31 (+3.11)

Expedia's 2014 Vacation Deprivation Study: Americans and Asian Workers Lag Well Behind Europeans in Vacationing
PR Newswire - Thu Nov 06, 5:00AM CST
Expedia.com®, one of the world's largest full service online travel sites1, today released the results of the 2014 Vacation Deprivation® study, an annual study of vacation habits among 7,855 employed adults across 24 countries in Asia Pacific, Europe, North America and South America. This is the study's 14th year. It continues to show a sharp disparity in vacation behavior across continents.
EXPE: 86.25 (+1.14)

Cramer's Mad Money - Actavis, What A Stock (11/5/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Nov 06, 4:57AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday November 5 CEO Interview: Brent Saunders, Actavis (NYSE: ACT ) Actavis ( ACT ) is up nearly 50% so far this year, thanks to its 8 cent earnings beat,...
KO: 42.38 (+0.06), AMZN: 304.62 (+4.76), ACT: 245.54 (-0.37), LMT: 186.96 (+0.81), FEYE: 32.14 (+1.52), SEAS: 18.50 (+0.11), FB: 75.22 (-0.38), TRIP: 73.17 (-0.48), DISCA: 32.39 (-0.23), CHUY: 22.80 (+0.78), KORS: 69.53 (-0.42), PANW: 109.56 (+2.54), PCLN: 1,113.97 (+19.36), PEP: 96.86 (+0.06), TWX: 77.48 (+0.48), MPC: 94.06 (-0.02), MRK: 58.81 (-0.53), MIDD: 92.57 (-1.43), EXPE: 86.25 (+1.14), EOG: 98.41 (-1.14), SIX: 39.88 (-0.17), TWTR: 39.80 (-0.51), BABA: 118.10 (+3.54)

Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 245.54 (-0.37), LMT: 186.96 (+0.81), XOM: 96.13 (-0.46), ILMN: 189.02 (+2.67), AKS: 6.60 (-0.02), KORS: 69.53 (-0.42), PAYX: 47.46 (+0.13), RIG: 29.29 (-0.42), EOG: 98.41 (-1.14), COST: 137.41 (-0.30), TWTR: 39.80 (-0.51), OXY: 87.62 (-0.42), KO: 42.38 (+0.06), SEAS: 18.50 (+0.11), TMO: 116.94 (+0.34), NUE: 53.68 (-0.50), TRIP: 73.17 (-0.48), DISCA: 32.39 (-0.23), CHUY: 22.80 (+0.78), LB: 76.28 (+0.67), GEO: 40.73 (-0.67), ESV: 39.86 (-1.45), MPC: 94.06 (-0.02), BAX: 70.59 (-0.02), MRK: 58.81 (-0.53), EXPE: 86.25 (+1.14), STI: 39.64 (-0.02)

Priceline Reports Strong Q3 Earnings, Guidance Hurts Shares - Analyst Blog
Sejuti Banerjea - Zacks Investment Research - Wed Nov 05, 1:31PM CST
Priceline.com reported strong results in the third quarter with earnings exceeding the Zacks Consensus Estimate on revenues that were in line.
EXPE: 86.25 (+1.14), MMYT: 29.35 (+0.77), OWW: 7.56 (-0.12), PCLN: 1,113.97 (+19.36)

TripAdvisor, HomeAway Shares Plummet On Q3 Earnings
at Investor's Business Daily - Wed Nov 05, 11:31AM CST
TripAdvisor (TRIP) and HomeAway (AWAY) stocks both plunged in the stock market today, after the two online travel companies issued disappointing Q3 earnings late Tuesday. Several investment houses lowered their price targets. Travel review and...
AWAY: 29.48 (+0.27), EXPE: 86.25 (+1.14), TRIP: 73.16 (-0.49)

20 Stocks That Could Beat the Market in November: Priceline, U.S. Steel Lead Way
at The Street - Wed Nov 05, 10:24AM CST
Which stocks have historically done the best in November, typically one of the best months to invest?
BIIB: 326.11 (+5.36), MNST: 107.20 (-1.19), ATI: 31.97 (-0.71), MON: 116.51 (+2.07), GMCR: 154.95 (+2.05), VMC: 65.61 (+0.50), EMR: 65.01 (+0.15), WDC: 97.69 (-0.01), VRSN: 60.29 (+0.49), URBN: 30.48 (-0.70), FSLR: 51.72 (+1.43), DE: 88.19 (-0.47), EXPE: 86.25 (+1.14), FLR: 65.86 (-0.43), FLS: 67.88 (-0.02), X: 36.95 (-0.62), ROK: 112.59 (+0.30), REGN: 384.97 (+7.13), MA: 84.82 (+0.02)

TripAdvisor Lags Q3 Earnings on High Expenses; Sales Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:10AM CST
TripAdvisor (TRIP) reported adjusted third-quarter 2014 earnings of 39 cents per share, missing the Zacks Consensus Estimate by 12 cents.
TRIP: 73.16 (-0.49), EXPE: 86.25 (+1.14), GOOGL: 560.42 (+8.60), PCLN: 1,113.97 (+19.36)

Priceline Outlook Disappoints; TripAdvisor EPS Misses
at Investor's Business Daily - Tue Nov 04, 5:45PM CST
Online travel stocks crashed Tuesday as a trio of companies posted earnings or gave guidance that lagged Wall Street expectations. Priceline (PCLN) started the damage early Tuesday, issuing disappointing guidance for the current quarter, partly on...
AWAY: 29.49 (+0.28), EXPE: 86.25 (+1.14), TRIP: 73.16 (-0.49), PCLN: 1,113.97 (+19.36)

HomeAway, Inc. Stock Slammed on Worse-Than-Expected Q4, Full Year Guidance
Tim Beyers, The Motley Fool - Motley Fool - Tue Nov 04, 5:21PM CST
Shares of HomeAway stock fell as much as 17% in late trading after issuing weak guidance for both the fourth quarter and full year. Here's a closer look at the final totals versus Wall Street's projections : HomeAway ...
AWAY: 29.49 (+0.28), EXPE: 86.25 (+1.14)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 238

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 12

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 315

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 286

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 83

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 110

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 183

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

Anytime Fitness Launches First Club in Dubai, UAE, Expanding Reach

Updated Category News Views 508

Anytime Fitness Sets Foot in Dubai with Grand Opening The new club in the Arjan district signifies a vital expansion of fitness services to the United Arab Emirates; members benefit from personalized wellness plans, state-of-the-art Technogym equipment, and SmartCoaching services available through the AF App. Purpose Brands LLC has announced the grand opening of its very...

Continue Reading
Crescent Biopharma's Strategic Partnership and Market Moves

Updated Category News Views 196

Crescent Biopharma's Recent Stock Activity Crescent Biopharma, Inc. (NASDAQ: CBIO) has been experiencing a notable fluctuation in its stock value lately. Shares initially showed a positive trend, indicating investor optimism following their recent announcement, but later reversed course and began to dip slightly. This change in trading comes as the company unveiled a...

Continue Reading
Investors Alert: Legal Developments for Snap Inc. Shareholders

Updated Category News Views 167

Important Update for Snap Inc. Shareholders If you have invested in Snap Inc. (NYSE: SNAP) and purchased shares in 2021 or earlier, there are significant legal developments that you should be aware of. A recent lawsuit is reportedly pending, and the Shareholders Foundation has urged impacted investors to take action. Details of the Lawsuit Against Snap Inc. The lawsuit...

Continue Reading
Understanding the Influence of Trump's Fiscal Policies on Debt

Updated Category News Views 493

Understanding the Influence of Trump's Fiscal Policies on Debt When it comes to government debt, being large isn't necessarily an advantage. Recent fiscal policies introduced by the Trump administration, including tariffs and the initiatives of the Department of Government Efficiency, aim to address the growing fiscal deficit. However, the overall effect may result in...

Continue Reading
Analyzing Sea's Short Interest Trends and Market Implications

Updated Category News Views 128

Understanding Sea's Short Interest Dynamics Sea's short percent of float has notably increased by 5.22% since the latest report. The company currently has 21.99 million shares sold short, which accounts for 7.46% of its total shares available for trading. Based on recent trading volumes, it would take an average of 5.24 days for traders to cover their short positions....

Continue Reading